Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 1Completed 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Other 1Gastrointestinal 1

Conditions

Stomatitis 2Head and Neck Neoplasms 2Stomatognathic Diseases 1Neoplasms by Site 1Neoplasms 1Mucositis 1Mouth Diseases 1Gastrointestinal Diseases 1Gastroenteritis 1Digestive System Diseases 1

Interventions

Low-Level Light Therapy 6Cisplatin 5avasopasem manganese 4Radiotherapy, Intensity-Modulated 4Standard of Care 3Injections 3Fibroblast Growth Factor 7 3golotimod 2Water 2Vitamin B 12 2Sodium Bicarbonate 2Saline Solution 2Radiotherapy 2RRx-001 2Propolis 2Mouthwashes 2Honey 2Gentamicins 2whole grape extract 1sargramostim 1samital 1regramostim 1oxycodone-acetaminophen 1dusquetide 1clazakizumab 1brilacidin 1alfacalcidol 1Xylitol 1Valacyclovir 1Traumeel S 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Stomatitis × golotimod × Head & Neck × Clear all
NCT01247246 2014-05-26

Study to Evaluate the Efficacy and Safety of Three Different Doses of SCV 07 in Attenuating Oral Mucositis in Subjects With Head and Neck Cancer

SciClone Pharmaceuticals

Phase 2 Unknown
160 enrolled
GastrointestinalHead & NeckOther

Digestive System Diseases, Gastroenteritis, Gastrointestinal Diseases, Head and Neck Neoplasms, Stomatognathic Diseases, Mouth Diseases, Neoplasms, Neoplasms by Site, Stomatitis, Mucositis

NCT00756951 2009-11-23

SCV-07 OM

SciClone Pharmaceuticals

Phase 2 Completed
59 enrolled
Head & Neck

Head and Neck Neoplasms, Stomatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡